| scholarly article | Q13442814 |
| P50 | author | Phillip J. White | Q42370049 |
| Wei-Jun Qian | Q58327364 | ||
| Christopher B Newgard | Q87867408 | ||
| P2093 | author name string | Richard D Smith | |
| Jian-Ying Zhou | |||
| Olga Ilkayeva | |||
| Thomas Scherer | |||
| Kevin L Grove | |||
| Christopher J Lynch | |||
| Andrew C Shin | |||
| Uwe Knippschild | |||
| Christoph Buettner | |||
| Claudia Lindtner | |||
| Elizabeth Zielinski | |||
| Nika Filatova | |||
| Martin Fasshauer | |||
| Ludger Scheja | |||
| Anna M Wolf | |||
| Amanda L Lapworth | |||
| Linus A Grundell | |||
| P2860 | cites work | Mediobasal hypothalamic leucine sensing regulates food intake through activation of a hypothalamus-brainstem circuit | Q42550972 |
| Insulin effect on leucine kinetics in type 2 diabetes mellitus. | Q44098799 | ||
| Hypothalamic insulin signaling is required for inhibition of glucose production | Q44212603 | ||
| Potential role of leucine metabolism in the leucine-signaling pathway involving mTOR. | Q44482073 | ||
| Insulin acutely increases fibrinogen production in individuals with type 2 diabetes but not in individuals without diabetes | Q44493445 | ||
| Branched-chain amino acid catabolism: unique segregation of pathway enzymes in organ systems and peripheral nerves | Q44579245 | ||
| Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats | Q44644463 | ||
| Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis | Q45286060 | ||
| Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy | Q46722537 | ||
| A molecular model of human branched-chain amino acid metabolism | Q46762438 | ||
| Role of brain insulin receptor in control of body weight and reproduction | Q47229086 | ||
| Obese men respond to cognitive but not to catabolic brain insulin signaling. | Q50888528 | ||
| Plasma Amino Acid Levels and Insulin Secretion in Obesity | Q51685623 | ||
| Insulin insensitivity is rapidly reversed in rats by reducing dietary fat from 40 to 30% of energy. | Q54262430 | ||
| Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM | Q72616560 | ||
| Spectrophotometric assay for measuring branched-chain amino acids | Q74318093 | ||
| Modulation of branched-chain amino acid oxidation in rat hemidiaphragms in vitro by glucose and ketone bodies | Q93644092 | ||
| Leptin therapy in insulin-deficient type I diabetes | Q24620780 | ||
| A C. elegans mutant that lives twice as long as wild type | Q27861054 | ||
| Hypothalamic mTOR signaling regulates food intake | Q28239714 | ||
| A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance | Q28240815 | ||
| Branched-chain amino acid metabolism | Q28267237 | ||
| Metabolite profiles and the risk of developing diabetes | Q29615359 | ||
| Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes | Q30982692 | ||
| Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling | Q33325905 | ||
| Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). | Q33609006 | ||
| Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia | Q34082873 | ||
| Disordered lipid metabolism and the pathogenesis of insulin resistance | Q34370965 | ||
| Regulation of branched-chain amino acid catabolism: nutritional and hormonal regulation of activity and expression of the branched-chain alpha-keto acid dehydrogenase kinase | Q34377914 | ||
| Hypothalamic K(ATP) channels control hepatic glucose production | Q34413202 | ||
| Do men develop type 2 diabetes at lower body mass indices than women? | Q34454220 | ||
| Consumption of a high-fat diet induces central insulin resistance independent of adiposity | Q34669531 | ||
| Brain insulin controls adipose tissue lipolysis and lipogenesis | Q34701526 | ||
| The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study | Q35033208 | ||
| Branched-chain [corrected] amino acid metabolism: implications for establishing safe intakes | Q36147749 | ||
| Short term voluntary overfeeding disrupts brain insulin control of adipose tissue lipolysis | Q36294800 | ||
| Central insulin action regulates peripheral glucose and fat metabolism in mice | Q36597490 | ||
| Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults | Q36629460 | ||
| Activation of hypothalamic S6 kinase mediates diet-induced hepatic insulin resistance in rats | Q36749704 | ||
| Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss | Q36851000 | ||
| Amino acids inhibit Agrp gene expression via an mTOR-dependent mechanism. | Q37001180 | ||
| Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men | Q37120388 | ||
| Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms | Q37165803 | ||
| Hypothalamic control of hepatic glucose production and its potential role in insulin resistance | Q37332394 | ||
| Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. | Q37399240 | ||
| Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. | Q37699221 | ||
| Gender difference in regulation of branched-chain amino acid catabolism | Q41816685 | ||
| The identification of novel potential injury mechanisms and candidate biomarkers in renal allograft rejection by quantitative proteomics | Q41926369 | ||
| P433 | issue | 5 | |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 898-909 | |
| P577 | publication date | 2014-10-09 | |
| P1433 | published in | Cell Metabolism | Q1254684 |
| P1476 | title | Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism | |
| P478 | volume | 20 |
| Q50084091 | A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk. |
| Q55287185 | Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes. |
| Q89412030 | Amino acids - lifesaver or killer in patients with diabetes? |
| Q61817179 | Associations Between Dietary Protein Sources, Plasma BCAA and Short-Chain Acylcarnitine Levels in Adults |
| Q92432449 | BRANCHED CHAIN AMINO ACIDS AT THE EDGE BETWEEN MENDELIAN AND COMPLEX DISORDERS |
| Q47835103 | Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums |
| Q27342729 | Branched-chain amino acid catabolism is a conserved regulator of physiological ageing |
| Q29306550 | Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export |
| Q28249276 | Branched-chain amino acids in metabolic signalling and insulin resistance |
| Q47987782 | Chronic Diseases and Lifestyle Biomarkers Identification by Metabolomics. |
| Q47413915 | Chronic Intranasal Insulin Does Not Affect Hepatic Lipids but Lowers Circulating BCAAs in Healthy Male Subjects. |
| Q37278842 | Defects in muscle branched-chain amino acid oxidation contribute to impaired lipid metabolism |
| Q41007154 | Effect of acute ozone exposure on the lung metabolomes of obese and lean mice |
| Q89674018 | Emerging Roles for Branched-Chain Amino Acid Metabolism in Cancer |
| Q90339347 | Enhancing cardiac glycolysis causes an increase in PDK4 content in response to short-term high-fat diet |
| Q57452396 | Enzyme promiscuity drives branched-chain fatty acid synthesis in adipose tissues |
| Q64120953 | Fine-scale haplotype mapping of MUT, AACS, SLC6A15 and PRKCA genes indicates association with insulin resistance of metabolic syndrome and relationship with branched chain amino acid metabolism or regulation |
| Q36206751 | Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis |
| Q36237292 | Global deletion of BCATm increases expression of skeletal muscle genes associated with protein turnover |
| Q34534015 | Human gut microbes impact host serum metabolome and insulin sensitivity |
| Q64259260 | Impaired Skeletal Muscle Branched-Chain Amino Acids Catabolism Contributes to Their Increased Circulating Levels in a Non-Obese Insulin-Resistant Fructose-Fed Rat Model |
| Q39958782 | Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels |
| Q38849153 | Insulin Receptor Signaling in POMC, but Not AgRP, Neurons Controls Adipose Tissue Insulin Action |
| Q92309048 | Malignant manipulaTORs of metabolism: suppressing BCAA catabolism to enhance mTORC1 activity |
| Q51835057 | Metabolic adaptations to HFHS overfeeding: how whole body and tissues postprandial metabolic flexibility adapt in Yucatan mini-pigs. |
| Q90036390 | Metabolic fingerprint of insulin resistance in human polymorphonuclear leucocytes |
| Q35658650 | Metabolite profiling in plasma and tissues of ob/ob and db/db mice identifies novel markers of obesity and type 2 diabetes |
| Q57107268 | Metabolites as regulators of insulin sensitivity and metabolism |
| Q92219580 | NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus |
| Q36245518 | NMR-based metabolic profiling in healthy individuals overfed different types of fat: links to changes in liver fat accumulation and lean tissue mass |
| Q51249812 | Plasma Amino Acids vs Conventional Predictors of Insulin Resistance Measured by the Hyperinsulinemic Clamp. |
| Q93200099 | Quantitative Analysis of the Whole-Body Metabolic Fate of Branched-Chain Amino Acids |
| Q90360189 | Recent Progress on Branched-Chain Amino Acids in Obesity, Diabetes, and Beyond |
| Q64122235 | SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms |
| Q47312518 | Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes |
| Q54108559 | The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase. |
| Q26744725 | The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism |
| Q28069578 | The Relationship between Branched-Chain Amino Acid Related Metabolomic Signature and Insulin Resistance: A Systematic Review |
| Q92493549 | The pattern of plasma BCAA concentration and liver Bckdha gene expression in GK rats during T2D progression |
| Q37125652 | The positive association of branched-chain amino acids and metabolic dyslipidemia in Chinese Han population |
| Q92051151 | Tissue-specific characterization of mitochondrial branched-chain keto acid oxidation using a multiplexed assay platform |
| Q90289606 | Type-2-Diabetes Alters CSF but Not Plasma Metabolomic and AD Risk Profiles in Vervet Monkeys |
| Q35856483 | Uric Acid Produces an Inflammatory Response through Activation of NF-κB in the Hypothalamus: Implications for the Pathogenesis of Metabolic Disorders |
| Q50084039 | Using Metabolomics to Explore the Role of Postmenopausal Adiposity in Breast Cancer Risk. |
| Q38851257 | What Have Metabolomics Approaches Taught Us About Type 2 Diabetes? |
Search more.